Structure

Physi-Chem Properties

Molecular Weight:  678.21
Volume:  637.477
LogP:  3.151
LogD:  2.823
LogS:  -7.178
# Rotatable Bonds:  6
TPSA:  167.74
# H-Bond Aceptor:  13
# H-Bond Donor:  5
# Rings:  8
# Heavy Atoms:  14

MedChem Properties

QED Drug-Likeness Score:  0.169
Synthetic Accessibility Score:  5.004
Fsp3:  0.412
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.859
MDCK Permeability:  5.674133717548102e-06
Pgp-inhibitor:  0.118
Pgp-substrate:  0.994
Human Intestinal Absorption (HIA):  0.876
20% Bioavailability (F20%):  0.453
30% Bioavailability (F30%):  0.988

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.173
Plasma Protein Binding (PPB):  90.86949920654297%
Volume Distribution (VD):  1.207
Pgp-substrate:  3.450939893722534%

ADMET: Metabolism

CYP1A2-inhibitor:  0.084
CYP1A2-substrate:  0.983
CYP2C19-inhibitor:  0.149
CYP2C19-substrate:  0.738
CYP2C9-inhibitor:  0.466
CYP2C9-substrate:  0.076
CYP2D6-inhibitor:  0.033
CYP2D6-substrate:  0.177
CYP3A4-inhibitor:  0.383
CYP3A4-substrate:  0.876

ADMET: Excretion

Clearance (CL):  4.341
Half-life (T1/2):  0.032

ADMET: Toxicity

hERG Blockers:  0.597
Human Hepatotoxicity (H-HT):  0.778
Drug-inuced Liver Injury (DILI):  0.978
AMES Toxicity:  0.885
Rat Oral Acute Toxicity:  0.104
Maximum Recommended Daily Dose:  0.971
Skin Sensitization:  0.635
Carcinogencity:  0.826
Eye Corrosion:  0.003
Eye Irritation:  0.009
Respiratory Toxicity:  0.91

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472845

Natural Product ID:  NPC472845
Common Name*:   CGQSZYLXZOKJEJ-VYCQBBBDSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  CGQSZYLXZOKJEJ-VYCQBBBDSA-N
Standard InCHI:  InChI=1S/C34H35ClN4O9/c1-36-18-12-46-21(11-19(18)40)47-13-20-31(45-3)29(41)30(42)34(48-20)39-27-15(8-6-9-16(27)35)23-25-24(32(43)38(2)33(25)44)22-14-7-4-5-10-17(14)37-26(22)28(23)39/h4-10,18-21,29-31,34,36-37,40-42H,11-13H2,1-3H3/t18-,19-,20+,21-,29+,30+,31+,34+/m0/s1
SMILES:  CO[C@@H]1[C@@H](CO[C@@H]2OC[C@@H]([C@H](C2)O)NC)O[C@H]([C@@H]([C@H]1O)O)n1c2c(Cl)cccc2c2c1c1[nH]c3c(c1c1c2c(=O)n(c1=O)C)cccc3
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3589063
PubChem CID:   128141
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000211] Indoles and derivatives
        • [CHEMONTID:0000210] Carbazoles
          • [CHEMONTID:0001865] Pyrrolocarbazoles
            • [CHEMONTID:0001866] Indolocarbazoles

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33195 actinomadura melliaura atcc 39691 Species Thermomonosporaceae Bacteria n.a. n.a. n.a. PMID[26091285]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens IC50 = 76.4 nM PMID[547729]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 106.2 nM PMID[547729]
NPT81 Cell Line A549 Homo sapiens Activity = 10.5 % PMID[547729]
NPT306 Cell Line PC-3 Homo sapiens Activity = 27.0 % PMID[547729]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 56.8 nM PMID[547729]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 20.8 % PMID[547729]
NPT602 Organism Mycobacterium smegmatis Mycobacterium smegmatis MIC > 60000.0 nM PMID[547729]
NPT312 Organism Saccharomyces cerevisiae Saccharomyces cerevisiae MIC = 7500.0 nM PMID[547729]
NPT729 Organism Micrococcus luteus Micrococcus luteus MIC > 60000.0 nM PMID[547729]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 60000.0 nM PMID[547729]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472845 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9419 High Similarity NPC472846
0.9336 High Similarity NPC472843
0.9252 High Similarity NPC472842
0.8755 High Similarity NPC472207
0.8431 Intermediate Similarity NPC1203
0.8031 Intermediate Similarity NPC107836
0.748 Intermediate Similarity NPC472844
0.7237 Intermediate Similarity NPC56109
0.7237 Intermediate Similarity NPC191382
0.7189 Intermediate Similarity NPC45048
0.7154 Intermediate Similarity NPC174788
0.7153 Intermediate Similarity NPC279589
0.7121 Intermediate Similarity NPC313884
0.7121 Intermediate Similarity NPC98371
0.7043 Intermediate Similarity NPC155444
0.7007 Intermediate Similarity NPC476514
0.6992 Remote Similarity NPC52254
0.6972 Remote Similarity NPC162860
0.6969 Remote Similarity NPC478157
0.6953 Remote Similarity NPC82070
0.695 Remote Similarity NPC475271
0.6941 Remote Similarity NPC476114
0.6929 Remote Similarity NPC31700
0.6905 Remote Similarity NPC477548
0.6905 Remote Similarity NPC478158
0.6892 Remote Similarity NPC54420
0.6887 Remote Similarity NPC281049
0.688 Remote Similarity NPC57453
0.6842 Remote Similarity NPC263937
0.6842 Remote Similarity NPC94428
0.6824 Remote Similarity NPC75634
0.678 Remote Similarity NPC33949
0.6757 Remote Similarity NPC477714
0.6742 Remote Similarity NPC476492
0.6742 Remote Similarity NPC476491
0.6719 Remote Similarity NPC204303
0.6718 Remote Similarity NPC477715
0.6704 Remote Similarity NPC132329
0.6704 Remote Similarity NPC478029
0.6703 Remote Similarity NPC476515
0.6691 Remote Similarity NPC471564
0.6654 Remote Similarity NPC316411
0.6643 Remote Similarity NPC473800
0.6642 Remote Similarity NPC89987
0.6641 Remote Similarity NPC274842
0.663 Remote Similarity NPC478028
0.6627 Remote Similarity NPC477065
0.6619 Remote Similarity NPC476493
0.6617 Remote Similarity NPC70155
0.6617 Remote Similarity NPC323198
0.6617 Remote Similarity NPC475258
0.6604 Remote Similarity NPC315062
0.6604 Remote Similarity NPC267853
0.6602 Remote Similarity NPC236424
0.6602 Remote Similarity NPC306644
0.6601 Remote Similarity NPC9482
0.6601 Remote Similarity NPC476874
0.6593 Remote Similarity NPC325976
0.6584 Remote Similarity NPC470205
0.6582 Remote Similarity NPC160898
0.658 Remote Similarity NPC244897
0.6577 Remote Similarity NPC313640
0.6576 Remote Similarity NPC107077
0.6576 Remote Similarity NPC223791
0.6573 Remote Similarity NPC478009
0.6573 Remote Similarity NPC478010
0.6564 Remote Similarity NPC244856
0.6562 Remote Similarity NPC474905
0.6553 Remote Similarity NPC471506
0.6543 Remote Similarity NPC475969
0.6543 Remote Similarity NPC475859
0.6538 Remote Similarity NPC54744
0.6535 Remote Similarity NPC193761
0.6535 Remote Similarity NPC155143
0.6527 Remote Similarity NPC249428
0.6527 Remote Similarity NPC312645
0.6523 Remote Similarity NPC14812
0.6517 Remote Similarity NPC909
0.6517 Remote Similarity NPC475338
0.651 Remote Similarity NPC476115
0.6506 Remote Similarity NPC477175
0.6506 Remote Similarity NPC470730
0.6504 Remote Similarity NPC64216
0.6502 Remote Similarity NPC478006
0.6496 Remote Similarity NPC475506
0.6493 Remote Similarity NPC192712
0.6486 Remote Similarity NPC475422
0.6477 Remote Similarity NPC314882
0.6473 Remote Similarity NPC87755
0.6464 Remote Similarity NPC472285
0.6462 Remote Similarity NPC320968
0.6458 Remote Similarity NPC165743
0.6457 Remote Similarity NPC195461
0.6457 Remote Similarity NPC79129
0.6457 Remote Similarity NPC49196
0.6457 Remote Similarity NPC81654
0.6457 Remote Similarity NPC249150
0.6457 Remote Similarity NPC313985
0.6455 Remote Similarity NPC79107
0.6455 Remote Similarity NPC472762
0.6455 Remote Similarity NPC475424
0.6451 Remote Similarity NPC172355
0.645 Remote Similarity NPC477979
0.6444 Remote Similarity NPC326363
0.6443 Remote Similarity NPC149708
0.6443 Remote Similarity NPC171317
0.6439 Remote Similarity NPC473310
0.6434 Remote Similarity NPC91179
0.6424 Remote Similarity NPC315467
0.6423 Remote Similarity NPC234999
0.6421 Remote Similarity NPC474877
0.6418 Remote Similarity NPC131273
0.6418 Remote Similarity NPC473441
0.6417 Remote Similarity NPC100321
0.6412 Remote Similarity NPC89508
0.6403 Remote Similarity NPC116701
0.6386 Remote Similarity NPC472436
0.6385 Remote Similarity NPC260909
0.6384 Remote Similarity NPC470729
0.6384 Remote Similarity NPC477176
0.6381 Remote Similarity NPC317701
0.6378 Remote Similarity NPC473640
0.6378 Remote Similarity NPC50503
0.6375 Remote Similarity NPC115282
0.6374 Remote Similarity NPC475778
0.6374 Remote Similarity NPC63279
0.6371 Remote Similarity NPC244741
0.6367 Remote Similarity NPC474896
0.6364 Remote Similarity NPC472027
0.636 Remote Similarity NPC469470
0.636 Remote Similarity NPC324091
0.636 Remote Similarity NPC477177
0.636 Remote Similarity NPC282033
0.636 Remote Similarity NPC469501
0.6357 Remote Similarity NPC476818
0.6353 Remote Similarity NPC293917
0.635 Remote Similarity NPC297642
0.635 Remote Similarity NPC234078
0.635 Remote Similarity NPC221100
0.635 Remote Similarity NPC472291
0.6344 Remote Similarity NPC472434
0.6344 Remote Similarity NPC470901
0.6343 Remote Similarity NPC31097
0.6341 Remote Similarity NPC473565
0.634 Remote Similarity NPC79386
0.6337 Remote Similarity NPC63031
0.6335 Remote Similarity NPC472097
0.6332 Remote Similarity NPC277350
0.6331 Remote Similarity NPC470843
0.6331 Remote Similarity NPC94541
0.633 Remote Similarity NPC272174
0.6324 Remote Similarity NPC195314
0.6324 Remote Similarity NPC69843
0.6322 Remote Similarity NPC469743
0.632 Remote Similarity NPC175474
0.631 Remote Similarity NPC314058
0.631 Remote Similarity NPC316359
0.631 Remote Similarity NPC315617
0.631 Remote Similarity NPC316018
0.6305 Remote Similarity NPC237901
0.6305 Remote Similarity NPC195788
0.6304 Remote Similarity NPC104712
0.6302 Remote Similarity NPC471192
0.6302 Remote Similarity NPC470731
0.6298 Remote Similarity NPC126066
0.6293 Remote Similarity NPC478011
0.6293 Remote Similarity NPC478012
0.6288 Remote Similarity NPC229348
0.6284 Remote Similarity NPC314957
0.6281 Remote Similarity NPC472435
0.628 Remote Similarity NPC17059
0.6279 Remote Similarity NPC476073
0.6276 Remote Similarity NPC242872
0.6276 Remote Similarity NPC263117
0.6276 Remote Similarity NPC125181
0.6275 Remote Similarity NPC227582
0.6271 Remote Similarity NPC314176
0.6268 Remote Similarity NPC153400
0.6265 Remote Similarity NPC199851
0.6265 Remote Similarity NPC294909
0.6265 Remote Similarity NPC254240
0.6265 Remote Similarity NPC252338
0.6265 Remote Similarity NPC128265
0.6265 Remote Similarity NPC312870
0.6263 Remote Similarity NPC310618
0.626 Remote Similarity NPC85066
0.626 Remote Similarity NPC181502
0.6259 Remote Similarity NPC229893
0.6255 Remote Similarity NPC323752
0.6255 Remote Similarity NPC213629
0.6255 Remote Similarity NPC165599
0.625 Remote Similarity NPC110602
0.625 Remote Similarity NPC31385
0.625 Remote Similarity NPC75726
0.625 Remote Similarity NPC153980
0.625 Remote Similarity NPC472110
0.625 Remote Similarity NPC6865
0.625 Remote Similarity NPC139291
0.625 Remote Similarity NPC131887
0.625 Remote Similarity NPC191489

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472845 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9256 High Similarity NPD7772 Phase 3
0.7889 Intermediate Similarity NPD7181 Phase 3
0.7606 Intermediate Similarity NPD7921 Approved
0.7444 Intermediate Similarity NPD6456 Discontinued
0.7326 Intermediate Similarity NPD7950 Approved
0.7326 Intermediate Similarity NPD7953 Approved
0.7326 Intermediate Similarity NPD7951 Approved
0.7326 Intermediate Similarity NPD7790 Approved
0.7326 Intermediate Similarity NPD7789 Approved
0.7326 Intermediate Similarity NPD7791 Approved
0.7326 Intermediate Similarity NPD7952 Approved
0.7237 Intermediate Similarity NPD7781 Approved
0.7237 Intermediate Similarity NPD7780 Approved
0.7198 Intermediate Similarity NPD6977 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD6978 Phase 2
0.7132 Intermediate Similarity NPD7731 Approved
0.7132 Intermediate Similarity NPD7730 Approved
0.7121 Intermediate Similarity NPD6976 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD7688 Phase 1
0.7109 Intermediate Similarity NPD6995 Phase 1
0.7077 Intermediate Similarity NPD7824 Approved
0.7054 Intermediate Similarity NPD7271 Approved
0.7047 Intermediate Similarity NPD8000 Clinical (unspecified phase)
0.6938 Remote Similarity NPD6615 Clinical (unspecified phase)
0.6903 Remote Similarity NPD7576 Discontinued
0.6899 Remote Similarity NPD6717 Clinical (unspecified phase)
0.6885 Remote Similarity NPD7717 Approved
0.6885 Remote Similarity NPD7716 Approved
0.6863 Remote Similarity NPD5807 Phase 2
0.686 Remote Similarity NPD6455 Phase 3
0.6825 Remote Similarity NPD8322 Phase 2
0.6811 Remote Similarity NPD7998 Clinical (unspecified phase)
0.677 Remote Similarity NPD7073 Clinical (unspecified phase)
0.6758 Remote Similarity NPD7454 Approved
0.6758 Remote Similarity NPD7455 Approved
0.6746 Remote Similarity NPD8114 Approved
0.6746 Remote Similarity NPD8115 Approved
0.6693 Remote Similarity NPD8093 Discontinued
0.6667 Remote Similarity NPD7769 Phase 3
0.6655 Remote Similarity NPD8463 Approved
0.6627 Remote Similarity NPD7727 Phase 2
0.6604 Remote Similarity NPD8372 Clinical (unspecified phase)
0.6567 Remote Similarity NPD8374 Phase 3
0.6564 Remote Similarity NPD7594 Clinical (unspecified phase)
0.6558 Remote Similarity NPD8279 Clinical (unspecified phase)
0.6531 Remote Similarity NPD8329 Phase 3
0.6527 Remote Similarity NPD7185 Discontinued
0.6527 Remote Similarity NPD8406 Clinical (unspecified phase)
0.6523 Remote Similarity NPD7001 Phase 3
0.6523 Remote Similarity NPD6732 Clinical (unspecified phase)
0.6519 Remote Similarity NPD3746 Discontinued
0.6509 Remote Similarity NPD7770 Phase 3
0.6502 Remote Similarity NPD6578 Clinical (unspecified phase)
0.6484 Remote Similarity NPD6288 Clinical (unspecified phase)
0.6481 Remote Similarity NPD8317 Phase 2
0.6481 Remote Similarity NPD8316 Phase 2
0.6471 Remote Similarity NPD5721 Clinical (unspecified phase)
0.6457 Remote Similarity NPD4600 Approved
0.6457 Remote Similarity NPD8524 Approved
0.6457 Remote Similarity NPD4601 Approved
0.6455 Remote Similarity NPD8289 Discontinued
0.6454 Remote Similarity NPD7944 Discontinued
0.6453 Remote Similarity NPD8046 Discontinued
0.6446 Remote Similarity NPD5450 Discontinued
0.6439 Remote Similarity NPD7878 Phase 2
0.6431 Remote Similarity NPD7817 Phase 1
0.6426 Remote Similarity NPD8421 Discontinued
0.6423 Remote Similarity NPD7809 Clinical (unspecified phase)
0.642 Remote Similarity NPD5426 Phase 3
0.6412 Remote Similarity NPD8094 Discontinued
0.6408 Remote Similarity NPD7776 Approved
0.6407 Remote Similarity NPD7888 Approved
0.6407 Remote Similarity NPD7887 Approved
0.6395 Remote Similarity NPD7958 Clinical (unspecified phase)
0.6395 Remote Similarity NPD7957 Phase 1
0.6393 Remote Similarity NPD7397 Approved
0.6393 Remote Similarity NPD7398 Approved
0.6385 Remote Similarity NPD8460 Approved
0.6385 Remote Similarity NPD8459 Approved
0.638 Remote Similarity NPD8375 Approved
0.6374 Remote Similarity NPD5040 Clinical (unspecified phase)
0.6371 Remote Similarity NPD8493 Clinical (unspecified phase)
0.637 Remote Similarity NPD7787 Discontinued
0.636 Remote Similarity NPD6204 Clinical (unspecified phase)
0.6357 Remote Similarity NPD8250 Phase 2
0.6357 Remote Similarity NPD7712 Clinical (unspecified phase)
0.6353 Remote Similarity NPD7621 Clinical (unspecified phase)
0.635 Remote Similarity NPD7502 Clinical (unspecified phase)
0.6347 Remote Similarity NPD7767 Approved
0.6346 Remote Similarity NPD7666 Phase 3
0.6346 Remote Similarity NPD7665 Phase 2
0.6337 Remote Similarity NPD8119 Discontinued
0.6336 Remote Similarity NPD7470 Discontinued
0.6336 Remote Similarity NPD8013 Clinical (unspecified phase)
0.6335 Remote Similarity NPD8371 Clinical (unspecified phase)
0.6328 Remote Similarity NPD8248 Clinical (unspecified phase)
0.6326 Remote Similarity NPD8112 Clinical (unspecified phase)
0.632 Remote Similarity NPD1534 Approved
0.6308 Remote Similarity NPD6838 Clinical (unspecified phase)
0.6305 Remote Similarity NPD8465 Approved
0.6305 Remote Similarity NPD8467 Approved
0.6305 Remote Similarity NPD8466 Approved
0.6301 Remote Similarity NPD8464 Clinical (unspecified phase)
0.6291 Remote Similarity NPD6142 Phase 3
0.6289 Remote Similarity NPD6661 Clinical (unspecified phase)
0.6284 Remote Similarity NPD7947 Clinical (unspecified phase)
0.6283 Remote Similarity NPD5001 Clinical (unspecified phase)
0.6272 Remote Similarity NPD7860 Clinical (unspecified phase)
0.627 Remote Similarity NPD6630 Clinical (unspecified phase)
0.6267 Remote Similarity NPD8364 Approved
0.6267 Remote Similarity NPD8363 Approved
0.6265 Remote Similarity NPD4501 Approved
0.6265 Remote Similarity NPD4500 Approved
0.6264 Remote Similarity NPD3757 Clinical (unspecified phase)
0.6263 Remote Similarity NPD8468 Phase 2
0.626 Remote Similarity NPD5835 Phase 3
0.626 Remote Similarity NPD5834 Phase 3
0.625 Remote Similarity NPD3320 Approved
0.625 Remote Similarity NPD8429 Approved
0.625 Remote Similarity NPD7708 Approved
0.625 Remote Similarity NPD3318 Approved
0.625 Remote Similarity NPD8427 Approved
0.625 Remote Similarity NPD3319 Phase 1
0.625 Remote Similarity NPD8428 Approved
0.6241 Remote Similarity NPD7218 Clinical (unspecified phase)
0.624 Remote Similarity NPD5021 Discontinued
0.6238 Remote Similarity NPD8349 Phase 1
0.623 Remote Similarity NPD4112 Clinical (unspecified phase)
0.6226 Remote Similarity NPD6787 Phase 2
0.6225 Remote Similarity NPD3607 Clinical (unspecified phase)
0.6224 Remote Similarity NPD8365 Clinical (unspecified phase)
0.6221 Remote Similarity NPD8425 Approved
0.6221 Remote Similarity NPD8426 Approved
0.622 Remote Similarity NPD7803 Approved
0.6215 Remote Similarity NPD8431 Approved
0.6214 Remote Similarity NPD6716 Phase 1
0.6211 Remote Similarity NPD6724 Clinical (unspecified phase)
0.6211 Remote Similarity NPD6664 Approved
0.6209 Remote Similarity NPD6986 Phase 1
0.6206 Remote Similarity NPD6180 Clinical (unspecified phase)
0.6206 Remote Similarity NPD8291 Clinical (unspecified phase)
0.6206 Remote Similarity NPD5488 Discontinued
0.6203 Remote Similarity NPD7970 Approved
0.6203 Remote Similarity NPD7971 Clinical (unspecified phase)
0.6202 Remote Similarity NPD8244 Phase 2
0.6201 Remote Similarity NPD7690 Clinical (unspecified phase)
0.6198 Remote Similarity NPD7704 Clinical (unspecified phase)
0.6196 Remote Similarity NPD4602 Approved
0.6194 Remote Similarity NPD6531 Approved
0.6194 Remote Similarity NPD6530 Approved
0.6182 Remote Similarity NPD8238 Clinical (unspecified phase)
0.6178 Remote Similarity NPD7903 Clinical (unspecified phase)
0.6178 Remote Similarity NPD5017 Discontinued
0.6175 Remote Similarity NPD5809 Phase 3
0.6169 Remote Similarity NPD8272 Phase 2
0.6165 Remote Similarity NPD7557 Clinical (unspecified phase)
0.6163 Remote Similarity NPD7000 Clinical (unspecified phase)
0.6163 Remote Similarity NPD6999 Discontinued
0.6162 Remote Similarity NPD8102 Discontinued
0.6162 Remote Similarity NPD8523 Approved
0.6159 Remote Similarity NPD7956 Approved
0.6159 Remote Similarity NPD7955 Approved
0.6159 Remote Similarity NPD4885 Approved
0.6157 Remote Similarity NPD8325 Phase 3
0.6157 Remote Similarity NPD8326 Phase 3
0.6157 Remote Similarity NPD5821 Approved
0.6157 Remote Similarity NPD8327 Clinical (unspecified phase)
0.6157 Remote Similarity NPD6710 Phase 3
0.6151 Remote Similarity NPD7070 Clinical (unspecified phase)
0.614 Remote Similarity NPD5482 Discontinued
0.6135 Remote Similarity NPD6610 Clinical (unspecified phase)
0.6134 Remote Similarity NPD8405 Clinical (unspecified phase)
0.6133 Remote Similarity NPD7024 Clinical (unspecified phase)
0.6128 Remote Similarity NPD7656 Approved
0.6128 Remote Similarity NPD8097 Phase 3
0.6128 Remote Similarity NPD7657 Approved
0.6128 Remote Similarity NPD8096 Phase 3
0.6122 Remote Similarity NPD6328 Clinical (unspecified phase)
0.6113 Remote Similarity NPD4900 Clinical (unspecified phase)
0.6111 Remote Similarity NPD6770 Approved
0.6109 Remote Similarity NPD4848 Phase 1
0.6107 Remote Similarity NPD6987 Phase 1
0.6107 Remote Similarity NPD8098 Approved
0.6107 Remote Similarity NPD5901 Discontinued
0.6105 Remote Similarity NPD3243 Approved
0.6105 Remote Similarity NPD2823 Clinical (unspecified phase)
0.61 Remote Similarity NPD6249 Phase 2
0.61 Remote Similarity NPD6248 Phase 2
0.6098 Remote Similarity NPD2443 Approved
0.6098 Remote Similarity NPD2442 Approved
0.6098 Remote Similarity NPD2510 Approved
0.6098 Remote Similarity NPD2509 Approved
0.6097 Remote Similarity NPD6218 Discontinued
0.6096 Remote Similarity NPD7564 Discontinued
0.6095 Remote Similarity NPD7711 Discontinued
0.6094 Remote Similarity NPD4348 Clinical (unspecified phase)
0.609 Remote Similarity NPD4614 Clinical (unspecified phase)
0.6089 Remote Similarity NPD6203 Clinical (unspecified phase)
0.6089 Remote Similarity NPD3280 Approved
0.6089 Remote Similarity NPD6210 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data